CEFT panel 23 peptides
$50.00 to US & $70.00 to Canada for most products. Final costs are calculated at checkout.
Background
Pool of 23 HLA class I restricted T cell epitopes from human cytomegalovirus, Epstein-Barr virus and influenza virus. Stimulates the release of IFN-gamma from CD8+ T cells in individuals with certain highly frequent HLA types (HLA: A1, A2, A3, A11, A24, A68, B7, B8, B27, B35, B44). Chosen epitopes are presented by the most common Caucasian HLA types, whose cumulative frequencies represent >100% of Caucasian individuals. Useful as a peptide specific positive control in ELISPOT, CTL and intracellular cytokine assays using human PBMC.
Product Details
Target Details
Application Details
Formulation
Shipping & Handling
This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information. All products of animal origin manufactured by Rockland Immunochemicals are derived from starting materials of North American origin. Collection was performed in United States Department of Agriculture (USDA) inspected facilities and all materials have been inspected and certified to be free of disease and suitable for exportation. All properties listed are typical characteristics and are not specifications. All suggestions and data are offered in good faith but without guarantee as conditions and methods of use of our products are beyond our control. All claims must be made within 30 days following the date of delivery. The prospective user must determine the suitability of our materials before adopting them on a commercial scale. Suggested uses of our products are not recommendations to use our products in violation of any patent or as a license under any patent of Rockland Immunochemicals, Inc. If you require a commercial license to use this material and do not have one, then return this material, unopened to: Rockland Inc., P.O. BOX 5199, Limerick, Pennsylvania, USA.
